JPRN-UMIN000015788招募中未知
Randomized Phase II Study Comparing 2 versus 3 Cycles of Neo-adjuvant Chemotherapy (Docetaxel+CDDP+5FU) for Patients with Resectable Advanced Esophageal Cancer - 2 versus 3 Cycle of Neo-adjuvant Chemotherapy for Esophageal Cancer
Department of surgery, Kindai univerisity0 个研究点目标入组 180 人开始时间: 2014年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)inoperable case due to dysfunction of primary organs (brain, heart, lung, liver, kidney) 2)cases with active double cancer 3)cases with serious drug sensitivity and its history 4)female during pregnancy or lactation 5)inappropriate cases determined by primary doctor 6)cases with mental disorder enough to be unable to understand context of the present study 7)cases who have underwent cisplatin-based chemotherapy 8)cases with positivity of HBs antigen
研究者
相似试验
进行中（未招募）
1 期
3 or 6 cycles of platinum-based chemotherapy prior to maintenance avelumab for bladder cancernresectable locally advanced or metastatic urothelial carcinomaMedDRA version: 20.0Level: LLTClassification code 10046714Term: Urothelial carcinoma bladderSystem Organ Class: 100000004864EUCTR2021-001975-17-ESQueen Mary University of London224
进行中（未招募）
不适用
Study comparing 3-weekly carboplatin + paclitaxel with or without concomitant and maintenance nintedanib (NINTEDANIB) in advanced or recurrent cervical carcinoma.Advanced or recurrent cervical carcinomaMedDRA version: 17.1Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000004864EUCTR2012-004076-19-ESZ Leuven / Belgian Gynaecological Oncology Group120
招募中
2 期
A randomized controlled phase II/III study comparing EBD combined with steroid to RIC combined with steroid for refractory anastomotic stricture after esophagectomy (JCOG1207: RICS study)Refractory anastomotic stricture after surgical resection for esophageal cancerJPRN-UMIN000014017Japan Clinical Oncology Group (JCOG)130
进行中（未招募）
2 期
A study comparing three vs six cycles of platinum-based chemotherapy before avelumab in advanced bladder cancerBladder cancerMalignant neoplasm of bladderCancerISRCTN15750433Queen Mary University of London224
Unknown
2 期
Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal CarcinomaNasopharyngeal CarcinomaNCT02871518Sun Yat-sen University236